GFT Technologies SE/ DE0005800601 /
04/06/2024 07:57:05 | Var. +0.1500 | Volume | Denaro10:10:33 | Lettera10:10:33 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
27.4500EUR | +0.55% | - Fatturato: - |
27.4000Quantità in denaro: 300 | 27.4500Quantità in lettera: 300 | 718.7 mill.EUR | 1.83% | 14.84 |
GlobeNewswire
10:00
HashiCorp brings The Infrastructure Cloud to Europe and expands Infrastructure and Security Lifecycl...
GlobeNewswire
10:00
FSLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fastly, Inc. Investors with Su...
GlobeNewswire
10:00
PERI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Perion Network Ltd. Investors ...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors w...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...
GlobeNewswire
10:00
IG Group Has Fully Integrated the Relay42 Customer Data Platform to Power Customer Acquisition and P...
GlobeNewswire
09:30
NewHydrogen CEO Steve Hill Discusses Challenges of Translating Cutting-edge Science into Marketable ...
GlobeNewswire
09:00
NXP and ZF Collaborate on SiC-Based Traction Inverters to Boost Electric Vehicle Powertrains
GlobeNewswire
09:00
World of Dypians Wins the BNB Chain DAU Incentive Program, Securing $60,000 in BNB
GlobeNewswire
09:00
ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody ...